Simvastatin induces apoptosis of cultured rat cardiomyocytes

Dalia El-Ani, Reuven Zimlichman

Research output: Contribution to journalArticlepeer-review

Abstract

Considering the therapeutic effect of statins (3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors) and simvastatin in patients with coronary heart disease, our first hypothesis was that simvastatin should inhibit apoptosis (programmed cell death) in angiotensin II-treated cultured myocytes. But after realizing that simvastatin stimulates apoptosis, we changed our hypothesis and began to study its apoptotic effect in primary cultured rat cardiomyocytes. We found that simvastatin induced apoptosis in a dose-dependent manner (0.1 to 3 μmol/L), as evidenced by the appearance of increased DNA fragmentation in agarose gels and characteristic apoptotic patterns in nuclei labeled with Hoechst 33342, as well as increased activity of caspase 3. FACS analysis of simvastatin-treated cardiomyocytes showing annexin V binding and propidium iodide exclusion ruled out the possibility of necrosis. Increased intracellular enzymatic activity of creatine phosphokinase, aldolase, and lactic dehydrogenase, markers for normal cell function, could reflect the hypertrophic effect of simvastatin. The results indicate that simvastatin-induced apoptosis in cultured heart cells is concentration-dependent and additive to the apoptotic effect of angiotensin II.

Original languageEnglish
Pages (from-to)325-338
Number of pages14
JournalJournal of Basic and Clinical Physiology and Pharmacology
Volume12
Issue number4
DOIs
StatePublished - 2001

Keywords

  • Hoechst 3342
  • angiotensin II
  • caspase-3 activity
  • heart

Fingerprint

Dive into the research topics of 'Simvastatin induces apoptosis of cultured rat cardiomyocytes'. Together they form a unique fingerprint.

Cite this